1. Home
  2. GRML vs AWRE Comparison

GRML vs AWRE Comparison

Compare GRML & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenland Mines Ltd. Common Stock

GRML

Greenland Mines Ltd. Common Stock

N/A

Current Price

$0.21

Market Cap

29.2M

Sector

N/A

ML Signal

N/A

Logo Aware Inc.

AWRE

Aware Inc.

HOLD

Current Price

$1.21

Market Cap

27.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRML
AWRE
Founded
N/A
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
27.7M
IPO Year
2022
1996

Fundamental Metrics

Financial Performance
Metric
GRML
AWRE
Price
$0.21
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.2M
40.4K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.02
52 Week High
$0.55
$2.95

Technical Indicators

Market Signals
Indicator
GRML
AWRE
Relative Strength Index (RSI) 47.25 48.96
Support Level $0.17 $1.18
Resistance Level $0.30 $1.38
Average True Range (ATR) 0.02 0.08
MACD 0.00 0.01
Stochastic Oscillator 53.14 53.85

Price Performance

Historical Comparison
GRML
AWRE

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

About AWRE Aware Inc.

Aware Inc provides biometric identity and authentication solutions. Its Awareness Platform transforms biometric data into actionable intelligence, allowing its clients to verify identities and authenticate access and transactions. The company's products span multiple biometric modalities, including fingerprint, face, iris, and voice. It offers: a broad range of biometrics software products and solutions, including platforms like AwareSDK, AwareABIS, AFIX Suite of Products, Awareness Platform, and WebEnroll; software components such as SDKs, APIs, and applications that customers use to develop their systems into more effective solutions; and several program management and software engineering services. Aware earns maximum revenue from the U.S., followed by the UK and the rest of the world.

Share on Social Networks: